The number of Xarelto lawsuits surpasses over 13,000 pending cases in courts around the nation. The lawsuits target Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. The suits claim that the company, along with Bayer AG, failed to provide consumers with adequate warnings about the potentially dangerous side effects of taking the medication. The lawsuits allege that the anticoagulant has the potential to cause bleeding, which can be difficult to stop.
Originally approved for use in 2011, Xarelto was reportedly supposed to help reduce the risk of blood clots as well as pulmonary embolism and deep vein thrombosis. It was originally provided to patients after having hip and knee replacement surgery and later approved for those who were at high risks of stroke and blood clots.
Patients taking Warfarin were encouraged to switch to Xarelto because it was a more convenient drug of choice that claimed to treat the same medical issues. Experts state that the major difference in the drugs is the ability to treat side effects. Patients on Warfarin can reverse uncontrolled bleeding by taking vitamin K injections. To date, there has been no way to stop the bleeding in patients who have taken Xarelto.
As first trials for Xarelto lawsuits begin at the end of March 2017, more and more patients have filed lawsuits and hundreds more are yet to come. If you believe you or your family has a Xarelto, call Scovern Law at 1-888-725-1890 or visit www.scovernlaw.com for more information. Case evaluations by patient advocates on staff at Scovern Law are free.